-
公开(公告)号:US07618947B2
公开(公告)日:2009-11-17
申请号:US11213593
申请日:2005-08-25
CPC分类号: C12N15/113 , C12N2310/11 , C12N2310/315 , C12N2310/321 , C12N2310/3341 , C12N2310/341 , C12N2310/346 , C12N2310/3525
摘要: Compounds, compositions and methods are provided for modulating the expression of HIF1-beta. The compositions comprise oligonucleotides, targeted to nucleic acid encoding HIF1-beta. Methods of using these compounds for modulation of HIF1-beta expression and for diagnosis and treatment of diseases and conditions associated with expression of HIF1-beta are provided.
摘要翻译: 提供化合物,组合物和方法用于调节HIF1-β的表达。 组合物包含靶向编码HIF1-β的核酸的寡核苷酸。 提供了使用这些化合物调节HIF1-β表达和用于诊断和治疗与HIF1-β表达相关的疾病和病症的方法。
-
公开(公告)号:US07799764B2
公开(公告)日:2010-09-21
申请号:US12578468
申请日:2009-10-13
申请人: Eric G. Marcusson , Scott W. Henry , Youngsoo Kim , Kenneth Dobie
发明人: Eric G. Marcusson , Scott W. Henry , Youngsoo Kim , Kenneth Dobie
CPC分类号: C12N15/113 , C12N2310/11 , C12N2310/315 , C12N2310/321 , C12N2310/3341 , C12N2310/341 , C12N2310/346 , C12N2310/3525
摘要: Compounds, compositions and methods are provided for modulating the expression of HIF1-beta. The compositions comprise oligonucleotides, targeted to nucleic acid encoding HIF1-beta. Methods of using these compounds for modulation of HIF1-beta expression and for diagnosis and treatment of diseases and conditions associated with expression of HIF1-beta are provided.
摘要翻译: 提供化合物,组合物和方法用于调节HIF1-β的表达。 组合物包含靶向编码HIF1-β的核酸的寡核苷酸。 提供了使用这些化合物调节HIF1-β表达和用于诊断和治疗与HIF1-β表达相关的疾病和病症的方法。
-
公开(公告)号:US20100113573A1
公开(公告)日:2010-05-06
申请号:US12578468
申请日:2009-10-13
申请人: Eric G. Marcusson , Scott W. Henry , Youngsoo Kim , Kenneth Dobie
发明人: Eric G. Marcusson , Scott W. Henry , Youngsoo Kim , Kenneth Dobie
IPC分类号: A61K31/7088 , C07H21/00 , A61P35/00 , A61P27/02 , C12N5/071
CPC分类号: C12N15/113 , C12N2310/11 , C12N2310/315 , C12N2310/321 , C12N2310/3341 , C12N2310/341 , C12N2310/346 , C12N2310/3525
摘要: Compounds, compositions and methods are provided for modulating the expression of HIF1-beta. The compositions comprise oligonucleotides, targeted to nucleic acid encoding HIF1-beta. Methods of using these compounds for modulation of HIF1-beta expression and for diagnosis and treatment of diseases and conditions associated with expression of HIF1-beta are provided.
-
-